ArticleJTO clinical and research reports2022

Overall Survival Benefits of First-Line Treatments for Asian Patients With Advanced EGFR-Mutated NSCLC Harboring L858R Mutation: A Systematic Review and Network Meta-Analysis.

Sik-Kwan Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.